2024 Annual Meeting | C119 - Pediatric Headache

Date Tuesday 04/16/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kenneth J. Mack, MD, PhD, FAAN

Topic(s) Child Neurology and Developmental Neurology, Headache

Learning Objectives Participants will appraise recent studies of new therapies in childhood headache, and synthesize with data from prior studies to apply a holistic approach to the treatment of children and adolescents with migraine and other headaches that ranges from lifestyle factors, to appropriate acute therapies, to prevention.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Brain Health

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic

Program Evaluations

Event Timeline
01:00 PM - 01:40 PM MDT	Speaker	Updates In Pediatric Headache Serena Orr, MD, MSc, FRCPC
01:40 PM - 02:20 PM MDT	Speaker	Blocks, Botox, and Buzzers Christina L. Szperka, MD
02:20 PM - 03:00 PM MDT	Speaker	Difficult Cases—Faculty Discussion Kenneth J. Mack, MD, PhD, FAAN

Faculty Disclosures
Kenneth J. Mack, MD, PhD, FAAN	Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbieVie. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. Dr. Mack has received publishing royalties from a publication relating to health care.
Christina L. Szperka, MD	The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. The institution of Dr. Szperka has received research support from NINDS. The institution of Dr. Szperka has received research support from PCORI. The institution of Dr. Szperka has received research support from International Headache Society.
Serena Orr, MD, MSc, FRCPC	The institution of Dr. Orr has received research support from Alberta Children's Hospital Research Institute. The institution of Dr. Orr has received research support from Canadian Institutes of Health Research. The institution of Dr. Orr has received research support from Department of Pediatrics, University of Calgary. The institution of Dr. Orr has received research support from American Headache Society. Dr. Orr has received publishing royalties from a publication relating to health care. Dr. Orr has a non-compensated relationship as a associate editor with Headache: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Orr has a non-compensated relationship as a editorial board member with Neurology that is relevant to AAN interests or activities. Dr. Orr has a non-compensated relationship as a editorial board member with American Migraine Foundation that is relevant to AAN interests or activities.

��ɫ��

��ɫ��